Rawford Pharmaceuticals has developed a new? drug, Vaxidene. The target amount for a single dose of Vaxidene is 9191 mg. Patients can receive as little as 8888 mg or as much as 9494 mg without experiencing any ill effects. Because of potential liability? issues, Crawford has determined that it is imperative that manufacturing be able to provide Six Sigma quality levels. At? present, the manufacturing process has a process mean of 9191 mg and a standard deviation of 8.158.15 mg
A. What are the upper and lower tolerance limits for vaxidene?
B. is crawfords's manufacturing process currently able to meet the dosage specifications at least 99.7% of the time? show work.